Where Ultragenyx Pharmaceutical Stands With Analysts
Over the past 3 months, 5 analysts have published their opinion on Ultragenyx Pharmaceutical (NASDAQ:RARE) stock. These analysts…
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell
• RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022.
• Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
Analysts have provided the following ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) within the last quarter: Bullish Somewhat Bullish Indifferent…
Analyst Expectations for Ultragenyx Pharmaceutical’s Future
Analysts have provided the following ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) within the last quarter: Bullish Somewhat Bullish Indifferent…
HC Wainwright & Co. Assumes Ultragenyx Pharmaceutical at Buy, Announces Price Target of $82
HC Wainwright & Co. analyst Ed Arce assumes Ultragenyx Pharmaceutical (NASDAQ:RARE) with a Buy rating and announces Price Target of $82.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 160 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 184 companies set new 52-week lows.
Where Ultragenyx Pharmaceutical Stands With Analysts
Analysts have provided the following ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) within the last quarter:
